The manufactured date and expiration date have been provided.Therefore, fields d4.Expiration date and h4.Device manufacture date have been populated.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
It was reported that a patient underwent a persistent atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and irrigation was not possible.Initially it was reported there was a catheter perfusion defect.There was a drip instead of conventional irrigation.Catheter was changed to resolve the incident.No patient consequences.On 14-mar-2024, additional information was received indicating the irrigation issue was noticed during use on the patient.The correct settings were set on the generator.The smartablate irrigation pump was working properly during but then had a bubble error when they wanted to ablate and the pump would turn to zero flow and automatically stop with the bubble error message.No bubbles were confirmed.Seems that the irrigation was not possible and stop the flow inside the catheter.Based on the additional information received, the event was reassessed as an mdr reportable malfunction.
|
Device investigation details: since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed a manufacturing record evaluation was performed for the finished device number lot 31233202l and no internal action related to the complaint was found during the review.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
On 16-may-2024, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|